Based-virtual Reality Diagnosis for Neuropsychiatric Diseases and Sleep/Wake Disorders
NCT ID: NCT02544295
Last Updated: 2015-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
590 participants
INTERVENTIONAL
2012-01-31
2019-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Usability of Virtual Reality in Subjects With Mild Cognitive Impairment or Alzheimer's Disease
NCT02176629
REMINISCENCES and EMOTIONS : Reminiscence Triggered by Virtual Reality for Older Adults With Mood Disorders
NCT04442594
Assessment of Attentional and Executive Disorders in Multiple Sclerosis Using Techniques of Virtual Reality
NCT01805336
Virtual Reality Training for Inhibitory Control in Neurocognitive Disorders
NCT06597591
Cognitive Rehabilitation Through Personalized Virtual Reality and Paper-and-pencil Interventions in the Alcohol Use Disorder Treatment.
NCT04639895
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Type of trial: Comparison of two parallel groups of healthy volunteers and patients with attention disorders, addictive, anxious, depressive or interfering with sleep/wake cycle.
Study design:
* standardized clinical interview with a sleep specialist, psychiatrist, or psychologist and rating scales,
* a virtual reality task. The primary outcome is to evaluate the diagnosis accuracy and the acceptability of the virtual tool to the referent standard (clinical interview and scales).
The secondary outcomes are:
* The comparison of healthy subjects and patients performances
* Tolerance, acceptability to exposure to virtual scenarios.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Clinical interview-Virtual reality task:1
Healthy controls will be assessed by a clinical interview by a psychiatrist, once, 1 day-duration and Virtual reality task, once, 1 day-duration
Clinical interview
Virtual reality task
Clinical interview-Virtual reality task:2
Patients will be assessed by a clinical interview by a psychiatrist, once, 1 day-duration and Virtual reality task, once, 1 day-duration
Clinical interview
Virtual reality task
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Clinical interview
Virtual reality task
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Having signed written informed consent
Exclusion Criteria
7 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Bordeaux
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pierre Philip
MD / PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre PHILIP, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Bordeaux
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Bordeaux
Bordeaux, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2011-A01418-33
Identifier Type: REGISTRY
Identifier Source: secondary_id
UBXS 2011-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.